138 related articles for article (PubMed ID: 17433298)
1. Inhibition of glycogen synthase kinase-3 suppresses the onset of symptoms and disease progression of G93A-SOD1 mouse model of ALS.
Koh SH; Kim Y; Kim HY; Hwang S; Lee CH; Kim SH
Exp Neurol; 2007 Jun; 205(2):336-46. PubMed ID: 17433298
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
3. The neuroprotective effect of the GSK-3β inhibitor and influence on the extrinsic apoptosis in the ALS transgenic mice.
Ahn SW; Kim JE; Park KS; Choi WJ; Hong YH; Kim SM; Kim SH; Lee KW; Sung JJ
J Neurol Sci; 2012 Sep; 320(1-2):1-5. PubMed ID: 22698482
[TBL] [Abstract][Full Text] [Related]
4. Role of GSK-3beta activity in motor neuronal cell death induced by G93A or A4V mutant hSOD1 gene.
Koh SH; Lee YB; Kim KS; Kim HJ; Kim M; Lee YJ; Kim J; Lee KW; Kim SH
Eur J Neurosci; 2005 Jul; 22(2):301-9. PubMed ID: 16045483
[TBL] [Abstract][Full Text] [Related]
5. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammation.
Koh SH; Kim Y; Kim HY; Cho GW; Kim KS; Kim SH
Eur J Neurosci; 2007 Apr; 25(7):1923-30. PubMed ID: 17439481
[TBL] [Abstract][Full Text] [Related]
7. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
[TBL] [Abstract][Full Text] [Related]
8. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase activator reduces motor neuronal cell death induced by G93A or A4V mutant SOD1 gene.
Koh SH; Roh H; Lee SM; Kim HJ; Kim M; Lee KW; Kim HT; Kim J; Kim SH
Toxicology; 2005 Sep; 213(1-2):45-55. PubMed ID: 15996807
[TBL] [Abstract][Full Text] [Related]
10. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Zhang X; Li L; Chen S; Yang D; Wang Y; Zhang X; Wang Z; Le W
Autophagy; 2011 Apr; 7(4):412-25. PubMed ID: 21193837
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin modulates the immune-inflammatory response of a SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS).
Noh MY; Cho KA; Kim H; Kim SM; Kim SH
Neurosci Lett; 2014 Jun; 574():53-8. PubMed ID: 24820540
[TBL] [Abstract][Full Text] [Related]
13. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Kim J; Kim TY; Cho KS; Kim HN; Koh JY
Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
[TBL] [Abstract][Full Text] [Related]
14. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
[TBL] [Abstract][Full Text] [Related]
15. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical study on the distribution of glycogen synthase kinase 3alpha in the central nervous system of SOD1(G93A) transgenic mice.
Chung YH; Joo KM; Kim DJ; Kim SS; Kim KY; Lee WB; Cha CI
Neurol Res; 2008 Nov; 30(9):926-31. PubMed ID: 18671898
[TBL] [Abstract][Full Text] [Related]
17. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
Apolloni S; Fabbrizio P; Amadio S; Volonté C
J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
19. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
[TBL] [Abstract][Full Text] [Related]
20. The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice.
Koh SH; Lee SM; Kim HY; Lee KY; Lee YJ; Kim HT; Kim J; Kim MH; Hwang MS; Song C; Yang KW; Lee KW; Kim SH; Kim OH
Neurosci Lett; 2006 Mar; 395(2):103-7. PubMed ID: 16356650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]